Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Courtney Nicholas

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Immunotherapy|May 11, 2011
Immunomodulatory cytokines as therapeutic agents for melanomaCourtney Nicholas, Gregory B Lesinski
Cancer Research|August 28, 2003
Targeted inactivation of p27kip1 is sufficient for large and small intestinal tumorigenesis in the mouse, which can be augmented by a Western-style high-risk dietWanCai Yang, Laura Bancroft, Courtney Nicholas, et al.
Cancer Immunology Research|July 5, 2017
Intratumoral STING Activation with T-cell Checkpoint Modulation Generates Systemic Antitumor ImmunityCasey R Ager, Matthew J Reilley, Courtney Nicholas, et al.
The American Journal of Pathology|March 29, 2005
Inactivation of p21WAF1/cip1 enhances intestinal tumor formation in Muc2-/- miceWancai Yang, Anna Velcich, Ioana Lozonschi, et al.
Anti-Cancer Drugs|June 9, 2015
Drug-induced RAF dimerization is independent of RAS mutation status and does not lead to universal MEK dependence for cell survival in head and neck cancersTuhina Mazumdar, Banibrata Sen, Yifan Wang, et al.
Science (New York, N.Y.)|March 2, 2002
Colorectal cancer in mice genetically deficient in the mucin Muc2Anna Velcich, WanCai Yang, Joerg Heyer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 6, 2007
Apigenin blocks lipopolysaccharide-induced lethality in vivo and proinflammatory cytokines expression by inactivating NF-kappaB through the suppression of p65 phosphorylationCourtney Nicholas, Sanjay Batra, Melissa A Vargo, et al.
Cancer Research|December 26, 2003
Gene expression profiling-based prediction of response of colon carcinoma cells to 5-fluorouracil and camptothecinJohn M Mariadason, Diego Arango, Qiuhu Shi, et al.
Journal for Immunotherapy of Cancer|September 20, 2019
Targeting interferon signaling and CTLA-4 enhance the therapeutic efficacy of anti-PD-1 immunotherapy in preclinical model of HPV<sup>+</sup> oral cancerStephanie Dorta-Estremera, Venkatesh L Hegde, Ravaen B Slay, et al.
Cancer Research|July 29, 2018
Mucosal HPV E6/E7 Peptide Vaccination in Combination with Immune Checkpoint Modulation Induces Regression of HPV<sup>+</sup> Oral CancersStephanie Dorta-Estremera, Renee L Chin, Gloria Sierra, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Immunotherapy|May 11, 2011
Immunomodulatory cytokines as therapeutic agents for melanomaCourtney Nicholas, Gregory B Lesinski
Cancer Research|August 28, 2003
Targeted inactivation of p27kip1 is sufficient for large and small intestinal tumorigenesis in the mouse, which can be augmented by a Western-style high-risk dietWanCai Yang, Laura Bancroft, Courtney Nicholas, et al.
Cancer Immunology Research|July 5, 2017
Intratumoral STING Activation with T-cell Checkpoint Modulation Generates Systemic Antitumor ImmunityCasey R Ager, Matthew J Reilley, Courtney Nicholas, et al.
The American Journal of Pathology|March 29, 2005
Inactivation of p21WAF1/cip1 enhances intestinal tumor formation in Muc2-/- miceWancai Yang, Anna Velcich, Ioana Lozonschi, et al.
Anti-Cancer Drugs|June 9, 2015
Drug-induced RAF dimerization is independent of RAS mutation status and does not lead to universal MEK dependence for cell survival in head and neck cancersTuhina Mazumdar, Banibrata Sen, Yifan Wang, et al.
Science (New York, N.Y.)|March 2, 2002
Colorectal cancer in mice genetically deficient in the mucin Muc2Anna Velcich, WanCai Yang, Joerg Heyer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 6, 2007
Apigenin blocks lipopolysaccharide-induced lethality in vivo and proinflammatory cytokines expression by inactivating NF-kappaB through the suppression of p65 phosphorylationCourtney Nicholas, Sanjay Batra, Melissa A Vargo, et al.
Cancer Research|December 26, 2003
Gene expression profiling-based prediction of response of colon carcinoma cells to 5-fluorouracil and camptothecinJohn M Mariadason, Diego Arango, Qiuhu Shi, et al.
Journal for Immunotherapy of Cancer|September 20, 2019
Targeting interferon signaling and CTLA-4 enhance the therapeutic efficacy of anti-PD-1 immunotherapy in preclinical model of HPV<sup>+</sup> oral cancerStephanie Dorta-Estremera, Venkatesh L Hegde, Ravaen B Slay, et al.
Cancer Research|July 29, 2018
Mucosal HPV E6/E7 Peptide Vaccination in Combination with Immune Checkpoint Modulation Induces Regression of HPV<sup>+</sup> Oral CancersStephanie Dorta-Estremera, Renee L Chin, Gloria Sierra, et al.
Pageof 3